Puriblood Medical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	117.35	110.67	125.27	137.44	54.59	38.65
Revenue Growth (YoY)	-7.28%	-11.65%	-8.86%	151.79%	41.25%	1149.06%
Cost of Revenue	52.85	49.52	118.75	78.78	48.99	14.27
Gross Profit	64.5	61.16	6.52	58.67	5.6	24.38
Selling, General & Admin	33.69	32.68	30.97	28.99	20.23	12.97
Research & Development	30.64	31.23	25.95	22.44	20.77	14.7
Operating Expenses	64.33	63.9	56.93	51.43	40.99	27.67
Operating Income	0.17	-2.74	-50.4	7.24	-35.4	-3.3
Interest Expense	-0.9	-0.8	-1.28	-1.07	-0.69	-1.05
Interest & Investment Income	1.49	1.88	1.95	0.58	0.07	0.01
Earnings From Equity Investments	-4.7	-1.06	-0.96	-0.13	-0.07	-1.53
Currency Exchange Gain (Loss)	-1.63	2.05	-0.02	0.54	-0.1	-0.1
Other Non Operating Income (Expenses)	5.76	1.73	0.03	-0.12	0.07	2.65
EBT Excluding Unusual Items	0.2	1.04	-50.68	7.04	-36.12	-3.32
Gain (Loss) on Sale of Investments	-8.62	-7.03	-3.75	10.05	-1.9	1.13
Gain (Loss) on Sale of Assets	-	-0.02	-	-0.15	-	-0.59
Pretax Income	-8.42	-6.01	-54.43	16.94	-38.02	-2.78
Income Tax Expense	-0.95	-0.64	-2.83	0.41	-	-
Net Income	-7.47	-5.37	-51.6	16.53	-38.02	-2.78
Net Income to Common	-7.47	-5.37	-51.6	16.53	-38.02	-2.78
Shares Outstanding (Basic)	14	14	14	14	12	9
Shares Outstanding (Diluted)	14	14	14	14	12	9
Shares Change (YoY)	-	-	-	22.10%	35.52%	-
EPS (Basic)	-0.52	-0.38	-3.63	1.16	-3.26	-0.32
EPS (Diluted)	-0.53	-0.38	-3.63	1.16	-3.26	-0.32
Free Cash Flow	-24.82	-31.74	20.4	-33.04	-46.83	-19.47
Free Cash Flow Per Share	-1.74	-2.23	1.43	-2.32	-4.02	-2.26
Gross Margin	54.97%	55.26%	5.21%	42.68%	10.26%	63.08%
Operating Margin	0.14%	-2.48%	-40.24%	5.27%	-64.84%	-8.53%
Profit Margin	-6.37%	-4.85%	-41.19%	12.03%	-69.66%	-7.19%
Free Cash Flow Margin	-21.15%	-28.68%	16.28%	-24.04%	-85.78%	-50.38%
EBITDA	6.65	3.97	-43.87	13.46	-30.59	0.07
EBITDA Margin	5.66%	3.59%	-35.02%	9.79%	-56.03%	0.18%
D&A For EBITDA	6.48	6.71	6.53	6.22	4.81	3.36
EBIT	0.17	-2.74	-50.4	7.24	-35.4	-3.3
EBIT Margin	0.14%	-2.48%	-40.24%	5.27%	-64.84%	-8.53%
Effective Tax Rate	-	-	-	2.39%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.